Literature DB >> 3952445

Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum aminotransferases.

R Hultcrantz, H Glaumann, G Lindberg, L H Nilsson.   

Abstract

The accidental finding of raised levels of serum aminotransferase levels may lead to extensive investigations of the liver in apparently healthy people. To identify diagnostic groups and their need for investigations, we have evaluated the results of all investigative procedures carried out in 149 asymptomatic patients with persistently raised serum levels of aminotransferases. Fatty liver was found in 64%. These patients often had a high body weight. A high alcohol intake and diabetes mellitus were also noted. Chronic active or persistent hepatitis was found in 20% of the patients. Six per cent had cirrhosis, 4% had alpha 1-antitrypsin deficiency, and 3.5% had hemochromatosis. Apart from ferritin, alpha 1-antitrypsin, and markers for hepatitis B, blood tests were of little value for distinguishing among different diagnostic groups. This was the case also for the imaging procedures, and neither liver scintigraphy nor ultrasonography was a reliable source of diagnostic information. The results of our study indicate that diagnosis in this group of patients cannot be made without liver biopsy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3952445     DOI: 10.3109/00365528609034632

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  28 in total

1.  Hepatitis C virus does not cause nonalcoholic steatohepatitis.

Authors:  D W Rogers; C H Lee; D C Pound; S Kumar; O W Cummings; L Lumeng
Journal:  Dig Dis Sci       Date:  1992-11       Impact factor: 3.199

2.  Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition.

Authors:  Michael Charlton; Anuradha Krishnan; Kimberly Viker; Schuyler Sanderson; Sophie Cazanave; Andrea McConico; Howard Masuoko; Gregory Gores
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-08-11       Impact factor: 4.052

Review 3.  Best practice in primary care pathology: review 5.

Authors:  W S A Smellie; J Forth; S Ryder; M J Galloway; A C Wood; I D Watson
Journal:  J Clin Pathol       Date:  2006-04-27       Impact factor: 3.411

4.  Biochemical "liver function tests".

Authors:  W Stuart A Smellie; Stephen D Ryder
Journal:  BMJ       Date:  2006-09-02

5.  An in vitro and in vivo study of the α-amylase activity of phaseolamin.

Authors:  Neire Moura de Gouveia; Fernanda Vieira Alves; Fabiana Barcelos Furtado; Danielli Luana Scherer; Antonio Vicente Mundim; Foued Salmen Espindola
Journal:  J Med Food       Date:  2014-03-20       Impact factor: 2.786

Review 6.  Clinical review of nonalcoholic steatohepatitis in liver surgery and transplantation.

Authors:  Amit D Tevar; Calissia Clarke; Jiang Wang; Steven M Rudich; E Steve Woodle; Alex B Lentsch; Michael L Edwards
Journal:  J Am Coll Surg       Date:  2010-04       Impact factor: 6.113

7.  How are abnormal results for liver function tests dealt with in primary care? Audit of yield and impact.

Authors:  P Sherwood; I Lyburn; S Brown; S Ryder
Journal:  BMJ       Date:  2001-02-03

8.  Associated liver enzymes with hyperlipidemic profile in type 2 diabetes patients.

Authors:  Noura Al-Jameil; Farah A Khan; Sadia Arjumand; Mohammad F Khan; Hajera Tabassum
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

9.  Usefulness of a liver biopsy in the evaluation of patients with elevated ALT values and serological markers of hepatitis viral infection: an AIGO study.

Authors:  A Andriulli; V Festa; G Leandro; M Rizzetto
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

10.  Liver disease in ulcerative colitis: an epidemiological and follow up study in the county of Stockholm.

Authors:  U Broomé; H Glaumann; G Hellers; B Nilsson; J Sörstad; R Hultcrantz
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.